Full Text View
Tabular View
No Study Results Posted
Related Studies
Medications Development for the Treatment of Cannabis Related Disorders (MTC)
This study has been completed.
Study NCT01204723   Information provided by University of Virginia

First Received on September 14, 2010.   Last Updated on May 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nicotine Withdrawal
Marijuana Dependence
Cannabis Dependence
Nicotine Dependence
Cannabis Abuse
Additional conditions recognized in this trial
Marijuana Abuse
Substance Withdrawal Syndrome
Tobacco Use Disorder
More general conditions related to this trial
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Placebo Aprepitant
Active Aprepitant
Additional drug interventions recognized in this trial
Analgesics, Non-Narcotic
Aprepitant
Molecular Mechanisms of Pharmacological Action
Narcotic Antagonists
Neurotransmitter Agents
Peripheral Nervous System Agents
Sensory System Agents
More general drug interventions related to this trial
Analgesics
Antiemetics
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of Virginia
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services